Two delta opioid receptor subtypes are functional in single ventral tegmental area neurons, and can interact with the mu opioid receptor. (1st September 2017)

• Record Type: Journal Article
• Authors: Margolis, Elyssa B.; Fujita, Wakako; Devi, Lakshmi A.; Fields, Howard L.
• Is Part Of: Neuropharmacology. Volume 123(2017)
• Page Start: 420
• Page End: 432
• Publication Date: 2017-09-01
• Subjects: Delta opioid receptor -- mu opioid receptor -- Cav2.1 -- Ventral tegmental area; [D-Pen2, D-Pen5]enkephalin (DPDPE) (PubChem CID:104787) -- [D-Ala2, Glu4]deltorphin (deltorphin II) (PubChem CID: 123795) -- [D-Ala2, N-Me-Phe4, Gly-ol5]-Enkephalin acetate salt (DAMGO) (PubChem CID: 5462471) -- D-Phe-Cys-Tyr-D-Trp-Arg-Thr-Pen-Thr-NH2 (CTAP) (PubChem CID: 10418702) -- H-Tyr-Tic-psi(CH2NH)Phe-Phe-OH (TIPP-psi) (PubChem CID: 5311481); Neuropsychopharmacology -- Periodicals; Autonomic Agents -- Periodicals; Neuropsychopharmacologie -- Périodiques; Neuropsychopharmacology; Periodicals; Electronic journals; 615.78
• DOI: 10.1016/j.neuropharm.2017.06.019
• Languages: English
• ISSNs: 0028-3908

Abstract

Abstract: The mu and delta opioid receptors (MOR and DOR) are highly homologous members of the opioid family of GPCRs. There is evidence that MOR and DOR interact, however the extent to which these interactions occur in vivo and affect synaptic function is unknown. There are two stable DOR subtypes: DPDPE sensitive (DOR1) and deltorphin II sensitive (DOR2); both agonists are blocked by DOR selective antagonists. Robust motivational effects are produced by local actions of both MOR and DOR ligands in the ventral tegmental area (VTA). Here we demonstrate that a majority of both dopaminergic and non-dopaminergic VTA neurons express combinations of functional DOR1, DOR2, and/or MOR, and that within a single VTA neuron, DOR1, DOR2, and MOR agonists can differentially couple to downstream signaling pathways. As reported for the MOR agonist DAMGO, DPDPE and deltorphin II produced either a predominant K + dependent hyperpolarization or a Cav 2.1 mediated depolarization in different neurons. In some neurons DPDPE and deltorphin II produced opposite responses. Excitation, inhibition, or no effect by DAMGO did not predict the response to DPDPE or deltorphin II, arguing against a MOR-DOR interaction generating DOR subtypes. However, in a subset of VTA neurons the DOR antagonist TIPP- Ψ augmented DAMGO responses; we also observed DPDPE or deltorphin II responses augmented by the MOR selective antagonist CTAP. These findings directly support the existence of two independent, stable forms of the DOR, and show that MOR and DOR can interact in some neurons to alter downstream signaling. Highlights: In VTA neurons, DOR agonists can postsynaptically activate a hyperpolarizing K + channel and/or a depolarizing Cav 2.1 current. Individual VTA neurons can respond similarly or differentially to DOR1, DOR2, and MOR activation. Direct opioid receptor agonist responses are observed in both dopamine and non-dopamine neurons. In a subset of VTA neurons we provide evidence for MOR-DOR physiological interactions.